These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1967541)

  • 1. Pretreatment of murine donor grafts with L-leucyl-L-leucine methyl ester: elimination of graft-versus-host disease without detrimental effects on engraftment.
    Blazar BR; Thiele DL; Vallera DA
    Blood; 1990 Feb; 75(3):798-805. PubMed ID: 1967541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells.
    Thiele DL; Charley MR; Calomeni JA; Lipsky PE
    J Immunol; 1987 Jan; 138(1):51-7. PubMed ID: 2946780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of murine graft-versus-host disease and bone marrow alloengraftment across the major histocompatibility barrier after donor graft preincubation with anti-LFA1 immunotoxin.
    Blazar BR; Carroll SF; Vallera DA
    Blood; 1991 Dec; 78(11):3093-102. PubMed ID: 1954395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of a facilitory role for NK 1.1-positive donor cells in engraftment across a major histocompatibility barrier in mice.
    Blazar BR; Soderling CC; Koo GC; Vallera DA
    Transplantation; 1988 May; 45(5):876-83. PubMed ID: 2897141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of leucyl-leucine methyl ester-sensitive cytotoxic cells in skin allograft rejection.
    Thiele DL; Geissler GH; Williams FH; Lipsky PE
    Transplantation; 1992 Jun; 53(6):1334-40. PubMed ID: 1604489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lethal graft-vs-host disease induced by a class II MHC antigen only disparity is not mediated by cytotoxic T cells.
    Thiele DL; Bryde SE; Lipsky PE
    J Immunol; 1988 Nov; 141(10):3377-82. PubMed ID: 3053897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal graft-versus-host disease is initiated by donor T cells distinct from classic cytotoxic T lymphocytes.
    Thiele DL; Eigenbrodt ML; Bryde SE; Eigenbrodt EH; Lipsky PE
    J Clin Invest; 1989 Dec; 84(6):1947-56. PubMed ID: 2531761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of lethal murine graft versus host disease by treatment of donor cells with L-leucyl-L-leucine methyl ester.
    Charley M; Thiele DL; Bennett M; Lipsky PE
    J Clin Invest; 1986 Nov; 78(5):1415-20. PubMed ID: 3534002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
    Thiele DL; Calomeni JA; Lipsky PE
    J Immunol; 1987 Oct; 139(7):2137-42. PubMed ID: 3309052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier.
    Blazar BR; Taylor PA; Snover DC; Bluestone JA; Vallera DA
    J Immunol; 1993 Jan; 150(1):265-77. PubMed ID: 8417127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the use of L-leucyl-L-leucine methyl ester in canine allogeneic marrow transplantation.
    Raff RF; Severns EM; Storb R; Graham TC; Sale G; Schuening FG; Appelbaum FR
    Transplantation; 1993 Jun; 55(6):1244-9. PubMed ID: 8516809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of donor mice with an alpha beta T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts.
    Drobyski WR; Majewski D
    Blood; 1996 Jun; 87(12):5355-69. PubMed ID: 8652851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of graft-versus-host disease using antibody to Thy 1. A role for complement in vivo.
    Hamilton BL; Harris D
    Transplantation; 1985 Jul; 40(1):90-6. PubMed ID: 2861676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes.
    Thiele DL; Lipsky PE
    J Immunol; 1986 Feb; 136(3):1038-48. PubMed ID: 2934477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of donor lymphocytes on the incidence of primary graft failure after allogeneic bone marrow transplantation in a murine model.
    Uharek L; Glass B; Gaska T; Gassmann W; Loeffler H; Mueller-Ruchholtz W
    Br J Haematol; 1994 Sep; 88(1):79-87. PubMed ID: 7803260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts.
    Blazar BR; Taylor PA; Smith S; Vallera DA
    Blood; 1995 Feb; 85(3):842-51. PubMed ID: 7833486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation across major histocompatibility barriers. V. Protection of mice from lethal graft-vs.-host disease by pretreatment of donor cells with monoclonal anti-Thy-1.2 coupled to the toxin ricin.
    Vallera DA; Youle RJ; Neville DM; Kersey JH
    J Exp Med; 1982 Mar; 155(3):949-54. PubMed ID: 6120991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucyl-leucine methyl ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease risk.
    Hsieh MH; Varadi G; Flomenberg N; Korngold R
    Biol Blood Marrow Transplant; 2002; 8(6):303-15. PubMed ID: 12108916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion of autologous cytotoxic cells leads to failure of unrelated, DLA-nonidentical marrow grafts.
    Loughran TP; Raff RF; Graham TC; Appelbaum FR; Schuening FG; Sale GE; Storb R
    Exp Hematol; 1990 Nov; 18(10):1126-31. PubMed ID: 2209768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of linked suppression in addition to the donor H-2 class I-specific unresponsiveness in recipient T cells by transfusing class I plus class II-disparate, but not class I alone-disparate, bone marrow cells.
    Muraoka S
    Cell Immunol; 1990 Jun; 128(1):261-76. PubMed ID: 1971530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.